Dottorato in Medicina Molecolare

 Capello M, Ferri-Borgogno S, Cappello P, Novelli F. α-Enolase: a promising therapeutical and diagnostic tumor target. FEBS J. 278:1064-74, 2011.

Bianco M, Aloisi A, Arima V, Capello M, Ferri-Borgogno S, Novelli F, Leporatti S, Rinaldi R. Quartz Crystal Microbalance with Dissipation (QCM-D) as tool to exploit antigen-antibody interactions in pancreatic ductal adenocarcinoma detection. Biosens Bioelectron. 42:646-52, 2013

Chiriacò MS, Primiceri E, Monteduro AG, Bove A, Leporatti S, Capello M, Ferri-Borgogno S, Rinaldi R, Novelli F, Maruccio G. Towards pancreatic cancer diagnosis by EIS biochips. Lab Chip. 13:730-4, 2013.

1. June 21-24, 2011. 6th ItPA ANNUAL NATIONAL CONGRESS, Turin (Italy).

Michela Capello, Paola Cappello, Federica C. Linty, Sammy Ferri-Borgogno, Roberto Chiarle, Aldo Scarpa, Paolo Pederzoli, Paola Nisticò, Michele Milella and Francesco Novelli (2011). Mouseto human autoantibody signature in pancreatic ductal adenocarcinoma.

2. September 4-7,  2011. HUPO 10th Annual World Congress, Geneva (Switzerland).

S. Ferri-Borgogno, M. Capello, W. Zhou, C. Fredolini, M. Principe, P. Cappello, A. Scarpa, P. Nisticò, M. Milella, E. Petricoin, F. Novelli (2011). Characterization of circulating autoantibodies to post-translationally modified alpha-enolase in pancreatic ductal adenocarcinoma.

3. September 4-7, 2011. HUPO 10th Annual World Congress, Geneva (Switzerland).

Michela Capello, Paola Cappello, Federica C. Linty, Sammy Ferri-Borgogno, Roberto Chiarle, Aldo Scarpa, Paolo Pederzoli, Paola Nisticò, Michele Milella and Francesco Novelli (2011). Mouseto human autoantibody signature in pancreatic ductal adenocarcinoma.

4. November 8, 2011. Riunione scientifica della Scuola Dianzani. Sassari, Italy.

M. Capello, P. Cappello, S. Ferri-Borgogno, W. Zhou, F.C. Linty, R. Chiarle, A. Scarpa, P. Pederzoli, E. Petricoin, P. Nisticò, M. Milella, F. Novelli. Autoantibody signature in pancreatic ductal adenocarcinoma.

5. June 18-21, 2012. AACR Special Conference, Pancreatic Cancer: Progress and Challenges, Hyatt Regency Lake Tahoe Lake Tahoe, NV (USA).

Capello M., Cappello P., Ferri-Borgogno S., Zhou W., Mandili G., Sperduti I, Linty F.C., Chiarle R., Scarpa A., Pederzoli P., Petricoin E., Nisticò P., Milella M. and Novelli F. Autoantibody Signature in Pancreatic Ductal Adenocarcinoma.

6. February 24 – Mar 1, 2013. Tumor metabolism. Keystone Simposia, Keystone, Colorado (USA).

Capello M, Principe M, Chattaragada MS, Riganti C, Zhou W, Ferri-Borgogno S, Rolla S, Liotta LA, Petricoin EF, Cappello P, Novelli F. The moonlighting glycolytic enzyme α-enolase as a therapeutic target in pancreatic cancer.

7. April 6-10,  2013. AACR Annual Meeting 2013. Washington DC (USA).

Capello M, Principe M, Chattaragada MS, Riganti C, Zhou W, Ferri-Borgogno S, Rolla S, Liotta LA, Petricoin EF, Cappello P, Novelli F. Can the moonlighting glycolytic enzyme α-enolase be a therapeutic target in pancreatic cancer?

8. June 20-21, 2013. Pancreatic Cancer, Salerno, Italy.

Michela Capello, Moitza Principe, Chiara Riganti, Weidong Zhou, Michelle S Chattaragada, Sammy Ferri-Borgogno, Simona Rolla, Lance A Liotta, Emanuel F Petricoin, Paola Cappello, Francesco Novelli Can the moonlighting glycolytic enzyme α-enolase be a therapeutic target in pancreatic cancer?

9. June 20-21, 2013. Pancreatic Cancer, Salerno, Italy.

Ferri-Borgogno Sammy, Capello Michela, Cappello Paola1, Zhou Weidong2, Mandili Giorgia1, Sperduti Isabella3, Maruccio Giuseppe4, Milella Michele3 and Novelli Francesco. Characterization of circulating autoantibodies to post-translationally modified α-Enolase in Pancreatic Cancer. Oral Presentation

10. August 22-27, 2013. 15th Congress of Immunology (ICI). Milano (Italy).

M. Capello, S. Ferri-Borgogno, P. Cappello, W. Zhou, G. Mandili, I. Sperduti, F. C. Linty, G. Maruccio, M. Milella, F. Novelli. Identification of Early Pancreatic Cancer-Associated Autoantibodies in Mouse and Human.

11. May 18-21, 2014 AACR Special Conference in Pancreatic Cancer: Innovations in Research and Treatment, Hyatt Regency New Orleans, New Orleans, LA (USA).

Michela Capello, Sammy Ferri-Borgogno, Moitza Principe, Michelle Samuel Chattaragada, Chiara Riganti, Weidong Zhou, Laura Follia, Lance A. Liotta, Emanuel F. Petricoin III, Paola Cappell1, Francesco Novelli. Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth.

November 2008 Vaccines in the Management of Cancer: where we are heading, First workshop “Fondazione Piccoli Cuori JOY”, Turin, Italy

June 2011. 6th ItPA (Italian Proteomics Association) Annual National Congress, Turin, Italy.

September 2011. HUPO 10th Annual World Congress, Geneva, Switzerland.

June 2012. AACR Special Conference, Pancreatic Cancer: Progress and Challenges, Hyatt Regency Lake Tahoe Lake Tahoe, NV (USA)

February 2013. 3rd General Assembly Meeting EPC-TM-Net “Targeting the tumor microenvironment to improve Pancreatic Cancer Prognosis”. Verona (Italy)

June 20-21, 2013. Pancreatic Cancer Meeting, Grand Hotel Salerno, Salerno, Italy

May 18-21, 2014 AACR Special Conference in Pancreatic Cancer: Innovations in Research and Treatment, Hyatt Regency New Orleans, New Orleans, LA (USA)

June 17, 2014 Workshop SIC: Targeted Therapy of Cancer: where we are heading, MBC, Via Nizza 52, Turin.

2012

11 January 2012, MBC, Via NIzza 52, Torino. "Endocytosis, stem cells ancd cancer", Dr.Paolo Di Fiore (Ospite: G. Tarone).

19 January 2012, MBC, Via Nizza 52, Torino. "Biomedical applications of recombinant antibody thechnology" Dr. Ario De Marc (Ospite: F. Novelli).

31 January 2012, Aula Cerms, Ospedale San Giovanni Battista, via Santena 5, Torino. "Multipurpose Biochips toward on-chip medicine". Dr. Giuseppe Maruccio (Ospite: F. Novelli).

27 March 2012, MBC, via Nizza 52, Torino. " Foxp3+ T regulatory cells: what do they really do?". Dr. Ethan M. Shevach (Ospite: G. Forni).

30 March 2012, S.C. Immunologia dei Trapianti, Az. Osp. San Giovanni Battista, via Santena 5, Torino. "HLA e vaccinazioni con peptidi per la cura dei tumori". Dr. Paolo Dellabona (Ospite: A. Amoroso).

13 April 2012, IRCC Candiolo. "Pancreatic Cancer: from molecular understanding to personalized treatment". Dr. Manuel Hidalgo.

01 June 2012, aula CeRMS, via Santena 5, Torino. "H63D mutation in HFE gene as disease-modifier in Pancreatic Cancer". Dr. L.Laghi and Dr. G.Delconte.

07 June 2012, MBC, via Nizza 52, Torino. "Cancer Day: from metabolism to immunotherapy".

14 September 2012, Aula Magna Del Rettorato, via Verdi 8, Torino. "D-Day"

 

2013

09 January 2013, Aula CeRMS, via Santena 5, Torino. "Human Th17: Origin, Differentiation and Disease”. Dr. Raffaele De Palma.

21 January 2013, MBC, via Nizza 52, Torino. "Mechanisms governing metastatic dormancy and reactivation”. Dr. Filippo Giancotti (Ospite: G. Tarone)

05 June 2013, MBC, via Nizza 52, Torino. "News and Views on PI3K”. Dr. Peter Vogt  (Ospite: E. Hirsh)

19 December 2013, MBC, Via Nizza 52, Torino. Seminari del Dipartimento di Biotecnologie Molecolari e Scienze della Salute

 

2014

13 February 2014, MBC, Via Nizza 52, Torino. “Stemness, reprogramming, regenerative medicine”. Seminari del Dipartimento di Biotecnologie Molecolari e Scienze della Salute (Coordinatori: B. Bussolati, E. Calautti)

04 March 2014, IRCC, Candiolo. Workshop on “ Mechanisms of cell mechanosensing”. Dr. Pere roca-Cusachs, Dr. Albrecht Schwab, Dr. Christoph Ballestrem, Dr. Kristian Franze (Coordinator: Dr. Guido Serini)

13 March 2014, MBC, via Nizza 52, Torino. "Molecular imaging of enzymatic activity in inflammation and cancer”. Dr. Alexei Bogdanov (Ospite: S. Aime)

20 March 2014, MBC, Via Nizza 52, Torino. “Inflammation, Immunotherapy”. Seminari del Dipartimento di Biotecnologie Molecolari e Scienze della Salute (Coordinatori: F. Novelli, E. Hirsh)

10 April 2014, MBC, Via Nizza 52, Torino. “From Chemistry to Biology”. Seminari del Dipartimento di Biotecnologie Molecolari e Scienze della Salute (Coordinatori: G. Caron e C. Medana)

14 April 2014, MBC, Via Nizza 52, Torino. “Shedding light on Merlin's wizardry”. Dr. Filippo Giancotti (Ospite: G. Tarone)

23 May 2014, The University Of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX. The Pancreas Cancer Seminar Series: "Penetrating the fortified walls of pancreatic cancer with Trojan horses, cannons and nanocapsules – a radiation oncology perspective". Sunil Krishnan M.D. (Associate Professor, Radiation Oncology Department).

27 May, 2014, The University Of Texas MD Anderson Cancer Center, South Campus Research Building 3, 1515 Holcombe Boulevard, Houston, TX. "The Cell Cycle and Cancer: Back to the Future". David Beach, Ph.D. (Queen Mary University, London).

27 May, 2014, The University Of Texas MD Anderson Cancer Center, ickens Tower, Floor 3, Distance Learning Center, 1515 Holcombe Boulevard, Houston, TX. "Targeting stress response pathways to halt cancer". Erica Sloan, Ph.D. (University of California Los Angeles).

29 October 2014, MBC, Via Nizza 52, Torino. “Unmet clinical needs: Basic Scientists meet Clinicians to fill the gap”. Seminari del Dipartimento di Biotecnologie Molecolari e Scienze della Salute (Coordinatore: G. Tarone) 

25 November 2014, MBC, Via Nizza 52, Torino. “Senescence therapy for cancer: the key role of the immune system”. Dr. Alberto Toso (Ospite: E. Hirsh)

 

2015

22 January 2015, MBC, Via Nizza 52, Torino. “Antitumoral effects of metformin on cancer stem cells: identification of novel molecular targets”. Dr. Roberto Würth (Ospite: V. Poli)

20 February 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, 1515 Holcombe Boulevard, Houston, TX. "Real time metabolic and molecular imaging of cancer by hyperpolarization". Dr. Pratip K. Bhattacharya, PhD (Cancer System Imagindì, MDACC).

20 February 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Smithville Auditorium, 1515 Holcombe Boulevard, Houston, TX. "An essential role for UTX in RA-induced bivalent resolution". Dr- Shilpa S. Dhar, PhD.

20 February 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Smithville Auditorium, 1515 Holcombe Boulevard, Houston, TX. "PRMT7 is a key regulator for ES cell stemness". Dr. Sung-Hun Lee, PhD.

24 February 2015, The University Of Texas MD Anderson Cancer Center, Mitchell Building, Floor 3, Onstead Auditorium, 1515 Holcombe Boulevard, Houston, TX. "New models for Pancreatic treatment" Davd Tuveson, MD, PhD. (Cold Spring Hoarbour Laboratory, N.Y.).

26 February 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 17, Room 4, 1515 Holcombe Boulevard, Houston, TX. "Live Tissue Slice Assay (LTSA): Ex Vivo testing of pancreatic adenocarcinoma patient-derived xenografts and inhibition of pancreatic adenocrcinoma in vivo with the compounds SerumAmyloid P and 1866". Davd Rofie, MD, PhD. (Department of Surgical Oncology, MDACC).

27 February 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room 6, 1515 Holcombe Boulevard, Houston, TX. "Directing A High Risk Pancreatic Cyst Clinic - The Johns Hopkins Perspective". Anne Marie O’Broin, M.D., Ph.D. (Johns Hopkins, Baltimore).

03 March 2015, The University Of Texas MD Anderson Cancer Center, Onstead Auditorium, Basic Science Research Building, Floor 3, 1515 Holcombe Boulevard, Houston, TX. "Shaping the Blood: Lessons from Chromatin and Single Cell RNA-Seq Dynamics ". Howard Gutstein, M.D. Department of Anesthesiology and PeriOp Medicine.

06 March 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. "Radioprotection by Prolyl Hydroxylase Domain-containing (PHD) Proteins: Implications for Improving the Therapeutic Ratio of XRT" Cullen Taniguchi, Gastrointestinal Medical Oncology / Sheikh Ahmed Center for Pancreatic Research.

11 March 2015, The University Of Texas MD Anderson Cancer Center, Onstead Auditorium, Basic Science Research Building, Floor 3, 1515 Holcombe Boulevard, Houston, TX. "Lecture:  Animal Welfare". Dr. Suzanne Craig, Responsible Conduct of Research Seminar Series.

20 March 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. "Arginine Methylation a New Enzyme, a New Binder Inhibitors". Dr. Mark Bedford Ph.D.

25 March 2015, The University Of Texas MD Anderson Cancer Center, Onstead Auditorium, Basic Science Research Building, Floor 3, 1515 Holcombe Boulevard, Houston, TX. "CyTOF User’s Group Meeting at University of Texas MD Anderson Cancer Center".

27 March 2015, The University Of Texas MD Anderson Cancer Center, AT&T Telehealth Classroom, Faculty Center (FC1.2002), 1515 Holcombe Boulevard, Houston, TX. "Novel Therapeutic Approaches in Lung and Pancreatic Cancers” Julien Sage, Ph.D. (Pediatrics and Genetics, Stanford University). 

02 April 2015, The University Of Texas MD Anderson Cancer Center, Onstead Auditorium, Basic Science Research Building, Floor 3, 1515 Holcombe Boulevard, Houston, TX. " The Making and Breaking of Nucleosomes” Karoline Luger, PhD. (Colorado State University, Howard Hughes Medical Institute Fort Collins, CO).

06 April 2015, The University Of Texas MD Anderson Cancer Center, AT&T Telehealth Classroom, Faculty Center (FC1.2002), 1515 Holcombe Boulevard, Houston, TX. "Deciphering the molecular choreography of protein synthesis and metabolism in Myc-driven cancers” John Thomas "Tom" Cunningham, Ph.D. (The University of California, San Francisco (UCSF), Department of Urology).

10 April 2015, The University Of Texas MD Anderson Cancer Center, Main Building R11.1100, Rooms 7&8, 1515 Holcombe Boulevard, Houston, TX. "Translating the Prostate Cancer Genome to the Clinic”. Scott Tomlins, MD, PhD.

17 April 2015, The University Of Texas MD Anderson Cancer Center, in Smithville Auditorium FC1.2002, 1515 Holcombe Boulevard, Houston, TX. “Role of Epigenome During Melanoma Progression”. Dr. Kunal Rai (MDACC, Genomic Medicine)

22 April 2015, The University Of Texas MD Anderson Cancer Center Onstead Auditorium, Basic Science Research Building, Floor 3, 1515 Holcombe Boulevard, Houston, TX. “Novel Nanomaterials for Cancer Diagnosis and Therapy, and Some Regulatory Concerns”. Dr. Valtencir Zucolotto, PhD (Nanomedicine and Nanotoxicology Laboratory Physics Institute of São Carlos University of São Paulo, Brazi)

01 May 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “About Chomsky, DNA patterns, non-coding RNAs and cancer patients”. George A. Calin, M.D., Ph.D. (Professor, Experimental Therapeutics )

05 May 2015, The University Of Texas MD Anderson Cancer Center, Life Science Plaza Building, Floor 9, Room LSP9.4101, 1515 Holcombe Boulevard, Houston, TX. “Charting the Course Forward for Immunoprofiling”. Clifford Hoyt (Oncology Fellow, Strategic alliances, PerkinElmer LSS)

07 May 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Targeting cancer stem cells using EMT signaling pathway”. Sendurai A. Mani, PhD.

13 May 2015, The University Of Texas MD Anderson Cancer Center, South Campus Research Building 4 (4SCR1.1110) Auditorium, 1515 Holcombe Boulevard, Houston, TX. “Epithelial to Mesenchymal Transition is dispensable for invasion and metastasis in pancreas cancer”. Julienne Carstens, Ph.D. (Postdoctoral Fellow, Dr. Kalluri’s Laboratory, Department of Cancer Biology)

15 May 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Atypical Protein Kinase Cs in Pancreatic Cancer”. Nicole R Murray Ph.D. (Assistant Professor of Pharmacology and a Senior Associate Consultant in the Department of Cancer Biology, Mayo Clinic Jacksonville, FL)

29 May 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Biomarker Discovery for Pancreatic Cancer”. Albert C Koong M.D. , Ph.D. (Professor Radiation Oncology- Radiation Therapy, Stanford School of Medicine)

5 June 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Understanding the Warburg effect.” Zhimin Lu, M.D., Ph.D. (Department of NeuroOncology) and “About Noam Chomsky, DNA patterns, non-coding RNAs and metabolism.” George Calin, Ph.D. (Department of Experimental Therapeutics)

10 June 2015, The University Of Texas MD Anderson Cancer Center, Hickey Auditorium, Main Building, Floor 11 (R11.1400), 1515 Holcombe Boulevard, Houston, TX. “Mechanisms of Malignant Progression.” Robert A. Weinberg, Ph.D. (Department of Biology, MIT, Cambridge, MA).

12 June 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Impact of diabetes on pancreatic cancer growth.” Mong- Hong Lee, BS ,Ph.D. (Professor, Molecular and Cellular Oncology).

18 June 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Identifying Metabolic Dependencies in Pancreatic Cancer”. Alec Kimmelman, Ph.D. (Associate Professor, The Dana Farber Cancer Institute Harvard University, Cambridge, MA).

10 July 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Modulating Tumor Stroma to Enhance Chemoradiation Therapy in Pancreatic Cancer”. Chun Li, Ph.D. (Professor, Cancer Systems Imaging).

22 July 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Targetting PI3K in BRCA Mutant Cancers”. Lewis C. Cantley, Ph.D. (and Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College/New York Presbyterian Hospital, NY).

24 July 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “Next Generation Cancer Immune Therapeutics”. Amy B Heimberger, M.D. (Professor, Neurosurgery).

4 August 2015, The University Of Texas MD Anderson Cancer Center, AT&T Auditorium, Main Building, Floor 2 (B2.4750), 1515 Holcombe Boulevard, Houston, TX. “A balancing act in metabolism: TRIM24”. Michelle Barton, Ph.D. (Dean, Graduate School of Biomedical Sciences).

4 August 2015, The University Of Texas MD Anderson Cancer Center, AT&T Auditorium, Main Building, Floor 2 (B2.4750), 1515 Holcombe Boulevard, Houston, TX. “Imaging Tumor metabolism with hyperbolized pyruvate”. Jim Bankson, Ph.D. (Associate Professor, Imaging Physics – Research).

2 September 2015, The University Of Texas MD Anderson Cancer Center South Campus Research Building 4 (Auditorium), 1515 Holcombe Boulevard, Houston, TX. “The Biology and Function of Exosomes in Cancer”. Raghu Kalluri, M.D., Ph.D. (Professor and Chairman, Department of Cancer Biology, Olla S. Stribling Distinguished Chair for Cancer Research, Director of Metastasis Research Center, Director of GSBS Cancer Biology Graduate Program).

2 September 2015, The University Of Texas MD Anderson Cancer Center, Pickens Tower, Floor 3, Room FCT3.5001, 1515 Holcombe Boulevard, Houston, TX. “BET protein bromodomain inhibitor-based cancer therapy”. Kapil Bhalla, M.D. (MBBS).

29 September 2015, DoCM Grand Rounds - 2015 John Mendelsohn Visiting Professor in Cancer Medicine, The University Of Texas MD Anderson Cancer Center: Hickey Auditorium, Main Building, Floor 11 (R11.1400), 1515 Holcombe Boulevard, Houston, TX. “Engineering the Cancer Genome”. Tyler E. Jacks, Ph.D.

2 October 2015, The University Of Texas MD Anderson Cancer Center: Pickens Tower, Floor 3, Distance Learning Center (FCT3.5001), 1515 Holcombe Boulevard, Houston, TX. “Nanotech-Enabled Analysis of Circulating Biomarkers for Pancreatic Cancer Detection”. Tony Hu, Ph.D. (Assistant Professor of Nanomedicine, Houston Methodist Research Institute).

6 October 2015, The University Of Texas MD Anderson Cancer Center: Onstead Auditorium, Basic Science  Research Building, Floor 3, near Elevator J, (S3.8012), 1515 Holcombe Boulevard, Houston, TX. “Insights into Mdm2 and Myc Reveal New Cancer Treatment Avenues”. Christine Eischen, Ph.D. (Vanderbilt University Nashville, TN).

16 October 2015, The University Of Texas MD Anderson Cancer Center: Pickens Tower, Smithville Auditorium, 1515 Holcombe Boulevard, Houston, TX. “BAF180 regulates cellular senescence, stem cell homeostasis, and energy stress response”. Dr. Boyi Gan.

27 October 2015, The University Of Texas MD Anderson Cancer Center: South Campus Research Building 4SCR1.1110, 1515 Holcombe Boulevard, Houston, TX. “The mitochondrial electron transport chain as an emerging target for cancer therapy”. Dieter A Wolf, MD.

28 October 2015, The University Of Texas MD Anderson Cancer Center: AT&T Auditorium, Main Building, Floor 2, 1515 Holcombe Boulevard, Houston, TX. “Disrupting the p53 tumor suppressor pathway”. Dieter A Wolf, MD.

30 October 2015, The University Of Texas MD Anderson Cancer Center: Pickens Tower, Smithville Auditorium, 1515 Holcombe Boulevard, Houston, TX. “Immune cells promoting pancreas cancer initiation and progression ”. Florencia McAllister, MD (Assistant Professor, Department of Clinical Cancer Prevention).

3 November 2015, The University Of Texas MD Anderson Cancer Center: Onstead Auditorium, Basic Science  Research Building, Floor 3, 1515 Holcombe Boulevard, Houston, TX. “Understanding Metabolic Heterogeneity in Cancer Cells and Tumors”. Ralph Deberardinis, M.D., Ph.D. (University of Texas Southwestern Dallas, TX).

6 November 2015, The University Of Texas MD Anderson Cancer Center: Hickey Auditorium, Main Building, Floor 11, 1515 Holcombe Boulevard, Houston, TX. “Targeting Cancers Engines, not its Drivers”. Dr. Gerard Evan, M.A., Ph.D., FRS, FMedSci.

11 November 2015, The University Of Texas MD Anderson Cancer Center: South Campus - 4SCR1.1110, 1515 Holcombe Boulevard, Houston, TX. “Akt, Metabolism, and Cancer Therapy: Surprising Lessons from Akt KO Mice”. Nissim Hay, Ph.D.

13 November 2015, The University Of Texas MD Anderson Cancer Center: South Campus - 4SCR1.1110, 1515 Holcombe Boulevard, Houston, TX. “The need for both edges of the sword: Early detection and new treatment approaches for pancreatic cancer mortality reduction”. Brian M. Wolpin, MD, MPH (Assistant Professor, Medicine, Dana-Farber/ Harvard Medical School).

11 October 2012, IRCC, Candiolo. "Must most metastatic cancer remain "incurable"?". James Dewey Watson, Nobel Prize Cold Spring Harbor Laboratory (USA)

14 December 2012, Aula CeRMS “From cancer patients’ immune response to prognostic markers and drugable pathways”. Paola Nisticò, Regina Elena National Cancer Institute, Roma

22 May, 2014, Clark Clinic MD Anderson, 1515 Holcombe Boulevard; Houston, Texas, USA. "A Worm's Tale: secrets of evolution and Immoratlity". Craig Mello, PhD (Nobel Prize Awardee, 2006)

February 2015 - December 2015

UT MD Anderson Cancer Center - Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research

Department of Pathology, Houston, TX, USA

Prof. Anirban Maitra's laboratory